128 related articles for article (PubMed ID: 1408329)
1. The LMI test in colon, breast and lung cancer long survivors.
Fazio M; Calabrese F; Coluccia C; Giacomasso S; Casadio C; Mancuso M; Negri L; Mastromatteo V
Panminerva Med; 1992; 34(2):60-4. PubMed ID: 1408329
[TBL] [Abstract][Full Text] [Related]
2. The lymphocyte locomotion assay in colon and breast cancer long survivors.
Fazio M; Calabrese F; Giacomasso S; Negri L; Mastromatteo V
Panminerva Med; 1993 Mar; 35(1):16-21. PubMed ID: 8391132
[TBL] [Abstract][Full Text] [Related]
3. Checking of carcinoma patients with the leukocyte migration technique (LMT) under agarose.
Emmrich F; Ambrosius H
Neoplasma; 1978; 25(4):483-91. PubMed ID: 80756
[TBL] [Abstract][Full Text] [Related]
4. DNCB sensitivity in cancer patients. A review based on sequential testing in 430 patients.
Bolton PM
Clin Oncol; 1975 Mar; 1(1):59-69. PubMed ID: 1106933
[No Abstract] [Full Text] [Related]
5. Studies on specificity of cell-mediated immunity to human tumors.
Takasugi M; Mickey MR; Terasaki PI
J Natl Cancer Inst; 1974 Dec; 53(6):1527-38. PubMed ID: 4140237
[No Abstract] [Full Text] [Related]
6. [Effect of tamoxifen on parameters of cell-mediated immunity in postmenopausal patients with breast carcinoma].
Mallmann P; Krebs D
Zentralbl Gynakol; 1991; 113(12):689-96. PubMed ID: 1927118
[TBL] [Abstract][Full Text] [Related]
7. In vitro evidence for increased cellular immunity to lung cancer antigen during Levamisole immunotherapy.
Urist MM; Boddie AW; Townsend CM; Holmes EC
J Thorac Cardiovasc Surg; 1977 Feb; 73(2):189-94. PubMed ID: 834057
[TBL] [Abstract][Full Text] [Related]
8. Demonstration of cell-mediated and blocking immune responses to tumor antigens in cancer patients with the colony-inhibition-in-gel test.
Cummings FJ; Heppner GH; Stolbach L; Calabresi P
Isr J Med Sci; 1973 Mar; 9(3):308-16. PubMed ID: 4710038
[No Abstract] [Full Text] [Related]
9. CD4+ CD25high regulatory T cells reduce T cell transendothelial migration in cancer patients.
Enarsson K; Lundin BS; Johnsson E; Brezicka T; Quiding-Järbrink M
Eur J Immunol; 2007 Jan; 37(1):282-91. PubMed ID: 17163448
[TBL] [Abstract][Full Text] [Related]
10. Demonstration of an antigen common to several varieties of neoplasia.
Lo Gerfo P; Krupey J; Hansen HJ
N Engl J Med; 1971 Jul; 285(3):138-41. PubMed ID: 5104234
[No Abstract] [Full Text] [Related]
11. Leukocyte migration inhibition among breast cancer patients in response to various oncogenic viruses.
Fukuda M; Wanebo HJ; Tsuei L; Ashikari R; Sarkar NH
J Natl Cancer Inst; 1980 Mar; 64(3):431-7. PubMed ID: 6243720
[TBL] [Abstract][Full Text] [Related]
12. [Study of cellular immunity indices in patients with malignant tumors].
Govallo VI; Grigor'eva MP; Kosmiadi GA
Vopr Onkol; 1973; 19(11):18-21. PubMed ID: 4522541
[No Abstract] [Full Text] [Related]
13. Peripheral leukocyte migration inhibition reactivity to breast cancer antigens in patients with breast cancer and in normal controls.
Brandes LJ; Goldenberg GJ
Cancer Res; 1976 Oct; 36(10):3707-10. PubMed ID: 953996
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of human leukocyte migration in agar by 3-M potassium chloride extracts of stomach, colon, and lung cancers.
Iwaki J; Akagi M; Sairenji T; Hinuma Y
J Natl Cancer Inst; 1979 Jul; 63(1):5-10. PubMed ID: 286834
[TBL] [Abstract][Full Text] [Related]
15. Studies on the detection of cellular immunity to human tumors by inhibition of macrophage migration.
Churchill WH; Rocklin RE
Natl Cancer Inst Monogr; 1973 Jun; 37():135-7. PubMed ID: 4713776
[No Abstract] [Full Text] [Related]
16. Hanganutziu-Deicher type-heterophile antigen-positive cells in human cancer tissues demonstrated by membrane immunofluorescence.
Ikuta K; Nishi Y; Shimizu Y; Higashi H; Kitamoto N; Kato S; Fujita M; Nakano Y; Taguchi T; Naiki M
Biken J; 1982 Mar; 25(1):47-50. PubMed ID: 6982042
[TBL] [Abstract][Full Text] [Related]
17. Cellular immunity to breast carcinoma and malignant melanoma.
Cochran AJ; Mackie RM; Thomas CE; Grant RM; Cameron-Mowat DE; Spilg WG
Br J Cancer Suppl; 1973 Aug; 1():77-82. PubMed ID: 4804293
[TBL] [Abstract][Full Text] [Related]
18. Effect of tamoxifen and high-dose medroxyprogesterone acetate (MPA) on cell-mediated immune functions in breast cancer patients.
Mallmann P; Dietrich K; Krebs D
Methods Find Exp Clin Pharmacol; 1990 Dec; 12(10):699-706. PubMed ID: 2151629
[TBL] [Abstract][Full Text] [Related]
19. Anti-tumor immunity in breast cancer evaluated by a computerized tube leukocyte adherence inhibition (LAI) assay.
Fink A; Shani A; Feldman B; Wechsler U; Pfeffermann R; Eliraz A; Offer S; Harpaz N; Bentwich Z
Eur J Surg Oncol; 1989 Feb; 15(1):17-9. PubMed ID: 2645173
[TBL] [Abstract][Full Text] [Related]
20. [Costus root oil test in cancer patients; correlation with tumor stage].
Takanami I; Utsunomiya T; Onishi H; Shinohara H; Besso T; Kondo T
Gan No Rinsho; 1983 Sep; 29(11):1319-22. PubMed ID: 6632212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
